Biogen Inc.
BIIB· Nasdaq
BIIBBiogen Inc.
Filed Apr 20, 2010 · 10-Q · 20 days after period end · 0000950123-10-036233
| Metric | Q1 2010 | Q1 2009 |
|---|---|---|
| Revenue | $1.11B | $1.04B |
| Net Income | $217.40M | $244.00M |
| EPS Diluted | $0.80 | $0.84 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biogen Inc. · CIK 875045 · Engraved from SEC EDGAR
ended Mar 31, 2010 · filed Apr 20, 2010 · 20 d after period end
